Back to search

Article

High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer

2021-02-20

Abstract excerpt

Pancreatic cancer has the lowest survival rate in all types of cancer. Pancreatic cancer patients are often diagnosed at advanced stages. A better therapeutic development for this devastating disease is urgently needed. Receptor for hyaluronan-mediated motility (RHAMM), not expressed in adult pancreas, has been suggested as a prognostic factor and a potential therapeutic target for pancreatic ductal adenocarcinoma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ec2fc52-fe74-5c5f-b7d2-2a24ec0d284c
DOI
10.1101/2021.02.19.432042
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancerDOI 10.1101/2021.02.19.432042
Select a neighboring publication to make it the new centre.